HEALTH● LOWJun 29 · Jun 29, 2026, 9:50 PM
Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing
Seeking Alpha Tech
Eli Lilly and Regeneron have been selected for an FDA pilot program aimed at enhancing drug manufacturing within the United States. This initiative seeks to strengthen domestic pharmaceutical production.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH36m agoTrump administration’s definition of ‘medically frail’ unlawful, according to federal judgeThe HillHEALTH49m agoNew World screwworm case reported in Arizona dogThe HillHEALTH1h agoThere is no other Stella for Ebola, By Azu IshiekwenePremium TimesHEALTH1h agoUS May Ease Access to Unproven PeptidesHuman Progress